Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?
Xenetic Biosciences shares surged over 160% intraday on October 8, 2025, closing up 123% at $9.58, with no new company news reported. Trading volume topped 30 million shares despite a public float of just 1.3 million. Analysts cited speculative trading and short covering as likely drivers. Recent clinical updates were last announced in July.
